Skip to content

Optimal timing for parenteral nutrition and delivery route of adequate protein in critical care trial

Optimal timing for parenteral nutrition and delivery route of adequate protein in critical care trial - PANDRA trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058441
Enrollment
720
Registered
2025-07-12
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically ill patients

Interventions

(When early enteral nutrition within 48 h after enrollment is possible) Protein is administered only through the enteral route (When early enteral nutrition within 48 h after enrollment is possible)

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 18 years old or older Requiring intensive care Oral intake nutrition is not possible

Exclusion criteria

Exclusion criteria: Enteral nutirion has been initiated before enrollment Withholding or withdrawing of care before enrollment Consent to participate in the trial cannot be obtained Ineligible to participate determined by a clinical physician

Design outcomes

Primary

MeasureTime frame
Abilities to perform basic activities of daily living (Barthel Index) at 90 days after randomization

Secondary

MeasureTime frame
28-day and 90-day mortality after randomization Quality of life (EQ-5D-5L) at 90 days after randomization Hospital-, ICU-, Ventilator-, RRT-free days up to 90 days after randomization Infectious diseases up to 28 days after randomization Muscle volume at 7 days and 28 days (or at discharge) after randomization, and changes in muscle volume from randomization to 7 days and 28 days (or at discharge) after randomization Changes in abilities to perform basic activities of daily living (Barthel Index) from the initiation of intensive care to 90 days after randomization Severe adverse events up to 90 days after randomization

Countries

Japan

Contacts

Public ContactRyo Yamamoto

Keio University School of Medicine Department of Emergency and Critical Care Medicine

ryoyamamoto@keio.jp0332251323

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026